Berardelli I

Department of Neurosciences, Mental Health and Sensory Organs, Faculty of Medicine and Psychology, Suicide Prevention Centre, Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035, Rome, 00189, Italy.

4 papers

ArticleKetamine

Beyond symptom reduction: Intranasal esketamine is associated with improved quality of life in treatment-resistant depression.

Pompili M, Sarubbi S, Di Biase G +5

Europe PMC2026

ArticleKetamine

Does Intranasal Esketamine Show Differential Efficacy with SSRIs versus SNRIs in Treatment-Resistant Depression?

Pompili M, Trocchia M, Di Biase G +5

Europe PMC2026

ArticleKetamine

Efficacy of Esketamine nasal spray in treatment-resistant depression: impact on depressive symptoms,hopelessness and suicide risk: A real-world evidence study

Pompili M, Trocchia M, Longhini L +5

Europe PMC2025

ArticleKetamine

Efficacy of Intranasal Esketamine in Treatment-Resistant Depression: A Six-Month Real-World Follow-Up Study of Depressive Symptoms, Hopelessness, and Suicide Risk.

Pompili M, Trocchia MA, Longhini L +5

Europe PMC2025